MSK Muscle disorders Flashcards Preview

Cardio > MSK Muscle disorders > Flashcards

Flashcards in MSK Muscle disorders Deck (31):

Types of muscle disorder:

1. Intrinsic diseases of muscle (myopathies)
a. Genetically determined
b. Acquired
2. Neurological diseases
3. Fatigue or effort syndrome
4. Tumours (rare)


Muscular Dystrophies: Characterised by

Progressive muscle weakness, defects in muscle prteins, fibre atrophy, and necrosis of muscle cells


Muscular Dystrophies: Types



Muscular Dystrophies: Most common and severe

Duchenne muscular dystrophy (DMD), which involves mutations of dystrophin gene.


Muscular Dystrophies: Becker

Less severe form of DMD


Muscular Dystrophies: Dystrophin

• Forms part of transmembrane “dystrophin – glycoprotein complex” that represents the costamere
• Prevents excessive stress on cell membrane during muscle contraction
• Stabilises sarcolemma and protects muscle fibre from disruption during contraction
• Possible role in regulating calcium levels


Muscular Dystrophies: Lack of Dystrophin in studies showed

• Increases susceptibility to membrane damage and allows excess calcium to penetrate cell membrane


Metabolic Myopathies: Includes disorders of

Glycogen metabolism, lipid metabolism or phosphagen system


Metabolic Myopathies: Cause

Impaired energy supply via affected pathways


Mitochondrial Myopathies: Involves

Structural abnormalities of mitochondria


Mitochondrial Myopathies: Cause

Dysfunction of mitochondrial pathways → impaired aerobic metabolism


Mitochondrial Myopathies: Often linked to

Mutations in mtDNA; mutations of nuclear DNA may cause dysfunction in respiratory chain


Disorders of muscle membranes (channelopathies) Periodic paralysis due to

Inexcitability of muscle that causes temporary paralysis or weakness


Disorders of muscle membranes (channelopathies) Myotonic dystrophy characterised by

Abnormal resting membrane potential


Congenital Myopathies: Definition

Myopathies that are present at birth or begin during infancy


Congenital Myopathies: Transmission

Usually hereditary and progress slowly


Congenital Myopathies: Characterised by

Specific morphologically abnormalities that cause muscle weakness and loss of muscle tone in infancy and delayed motor development during childhood


Diagnosis and investigation of muscle disease:

1. DNA analysis
2. Muscle biopsy
3. Exercise testing
4. Electromyography
5. Plasma creatine kinase analysis


DNA Analysis:

1. Used to investigate disorders with major genetic component
2. Single gene disorders (caused by mutation in one gene) are easiest to identify
3. Possible to predict gene involved from the aberrant protein (e.g. dystrophin in DMD)


Muscle Biopsy: Enzymes of glycolysis

Stain for enzymes involved in glycolysis e.g. PFK and myophospharylase → used to identify such as myophosphorylase defiency (McArdle’s disease)


Muscle Biopsy: Storage Products

Periodic acid-Schiff Stains for Glycogen
Demonstrates abnormal glycogen storage in patients with glycogenesis


Muscle Biopsy: Enzymes of oxidative metabolism

Oxidative enzymes e.g. NADH, cytochrome C oxidase, SDH used in diagnosis of mitochondrial myopathies
CCO used to demonstrate respiratory chain abnormalities
SDH used as marker enzyme for mito
→ Indicates abnormalities in mit distribution e.g. in mito myopathies, core disease, MD


Ischaemic exercise disease: Used to investigate

Certain metabolic myopathies


Ischaemic exercise disease: Process

• Baseline blood sample taken at rest
• Circulation of forearm occluded whilst subject exercises forearm for fixed time or t o exhaustion
• Circulation restored, blood samples taken immediately after exercise and during recovery
• Blood analysed for lactate and ammonia


Ischaemic exercise disease: Failure to produce lactate

• Disorders of glycogen metabolism e.g. myophosphorylase defiency


Ischaemic exercise disease: Impaired ammonia production indicative

Of myoadenylate deaminase defiency (MADD)


Incremental/steady state exercise test: Aids

Diagnosis/assessment of mito myopathies


Incremental/steady state exercise test: Process

1. Baseline blood sample taken at rest
2. Subject exercises at series of incremental loads on bicycle ergometer or treadmill
3. At each load, blood samples taken for lactate analysis, further samples taken during recovery


Incremental/steady state exercise test: Elevated lactate levels for

Given workload indicates increased conversion of pyruvate to lactate



1. Intramuscular (needle) EMG used to investigate alterations in muscle activity as a result of disease
2. Most commonly studied features are:
a. Insertional activity
b. Spontaneous activity
c. MUAP characteristics
d. Recruitment patterns
3. EMG changes occur as a result of membrane disorders that affect excitability of cell membrane, or as result of marked atrophy or necrosis.


Plasma Creatine kinase analysis:

1. Plasma CK levels may rise temporailiy in healthy subjects in healthy subjects following eccentric exercise (as shown in figure)
2. Elevated plasma CK levels indicate damage to muscle cell membrane, and are common feature of DMD.

Decks in Cardio Class (108):